1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > Diagnostic Imaging Market Trends
  5. > Diagnostic Imaging Global Market – Forecast To 2022

Diagnostic Imaging Global Market – Forecast To 2022

  • March 2016
  • -
  • IQ4I Research & Consultancy Pvt. Ltd
  • -
  • 413 pages

Summary

Diagnostic imaging is a non-invasive diagnosis and treatment of some of the most life threatening diseases such as cancer and heart diseases and they have nearly eliminated the need for exploratory surgery. It is identified as one of the largest markets among the healthcare sector. Imaging techniques would allow diagnosing, treating and curing patients without causing any harmful side effects. The different diagnostic imaging modalities include X-ray systems, Computed Tomography (CT) Scanners, Magnetic Resonance Imaging (MRI) systems, Ultrasound systems and Nuclear imaging systems. According to IQ4I estimates, the diagnostic imaging global market is expected to reach $38,315 million by 2022.

Globally Diagnostic imaging technologies market is segmented into product outlook, technology outlook, applications and end-users. Product outlook is further segmented into Computed Tomography (CT) scanners, Nuclear Imaging (NI) equipment, Magnetic Resonance Imaging (MRI) systems, Ultrasound scanners and X-ray devices and others. Technology outlook is also alienated again into Computed Tomography (CT), Nuclear Imaging (NI), Magnetic Resonance Imaging (MRI), Ultrasound, x-ray and others. Application outlook is classified into Cardiovascular Diseases (CVD’s), Cancer, Neurological disorders, abdominal related problems, Orthopedic related problems, gynecology related problems and others. Depending on the end-users, the market is segmented into hospitals, private diagnostic laboratories and research laboratories.
Globally among the diagnostic imaging techniques, ultrasound is the most frequently used imaging procedure with more than 900 million exams per year followed by X-ray, CT, MRI, and nuclear medicine. This indicates that diagnostic imaging market contributes to its highest share among all imaging techniques.

This report studies the Diagnostic imaging technologies global market over the forecast period (2016-2022). The market is expected to grow at a mid single digit CAGR from 2015 to 2022. Increasing incidence of life threatening diseases with growth of aged cohort, growing awareness among people about early disease diagnosis and improving healthcare expenditure in emerging markets, high number of ongoing research activities across the globe are the factors driving the market growth. High cost of diagnostic imaging systems, imposition of excise tax on sale of medical devices and risk of radiation exposure limiting the usage of some diagnostic imaging systems are the factors hampering the market growth.

North America holds the largest share in the global diagnostic imaging market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR of 5.8% from 2015 to 2022. The Asian and Latin American countries represent the fastest growing markets due to increasing government support for research and rising industry and academic partnerships for pre-clinical research. But still the factors such as economic slowdown, pricing pressures may compel the companies to focus on Asian markets.

The top key market players in the global diagnostic imaging market are Analogic Corporation (U.S.), GE Healthcare (U.K), Philips Healthcare (Netherland), Siemens Healthcare (U.S.), Toshiba Medical Systems Corporation (Japan), Hitachi Medical Corporation (Japan), Carestream Health, Inc. (U.S.), Hologic, Inc. (U.S.), Samsung Medison (South Korea) and Shimadzu Corporation (Japan). Among them GE Healthcare (U.K.) holds the leadership position in the global market by launching many new products into the market.

Table Of Contents

Diagnostic Imaging Global Market - Forecast To 2022

1 EXECUTIVE SUMMARY 25
2 INTRODUCTION 33
2.1 KEY TAKE AWAYS 33
2.2 REPORT DESCRIPTION 34
2.3 MARKETS COVERED 35
2.4 STAKEHOLDERS 38
2.5 RESEARCH METHODOLOGY 38
2.5.1 MARKET SIZE ESTIMATION 39
2.5.2 MARKET BREAKDOWN AND DATATRIANGULATION 42
2.5.3 SECONDARY SOURCES 43
2.5.4 PRIMARY SOURCES 44
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES 44
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES 45
2.5.7 ASSUMPTIONS 45
3 MARKET ANALYSIS 47
3.1 INTRODUCTION 47
3.2 MARKET SEGMENTATION 48
3.3 FACTORS INFLUENCING MARKET 49
3.3.1 DRIVERS AND OPPORTUNITIES 50
3.3.1.1 Increasing incidence of life threatening diseases with growth of aged cohort 50
3.3.1.2 Growing awareness among people about early disease diagnosis and improving healthcare expenditure in emerging markets 50
3.3.1.3 Increasing investments by government as well as private bodies in mature and emerging markets to modernize diagnostic imaging 51
3.3.1.4 Increasing number of private diagnostic centers offering diagnostic imaging services 52
3.3.1.5 High number of ongoing research activities across the globe 52
3.3.1.6 Increasing application of diagnostic imaging systems 52
3.3.1.7 Technological advancements in diagnostic imaging modalities with its use in multiple fields to increase its adoption by hospitals 53
3.3.1.8 Extenuating the alleged risks associated with diagnostic imaging and implementing sustainable practices 54
3.3.1.9 Dedicated RandD and product development by key players 54
3.3.2 RESTRAINTS AND THREATS 55
3.3.2.1 High cost of diagnostic imaging systems 55
3.3.2.2 Imposition of excise tax on the sale of medical imaging systems 56
3.3.2.3 Risk of radiation exposure limiting the use of some diagnostic
imaging systems 56
3.3.2.4 Lack of skilled personnel and reimbursement cuts for diagnostic
imaging procedures in some countries 57
3.3.3 PROBLEM AREAS 57
3.3.3.1 Shortage in supply of technetium99m for SPECT systems 57
3.3.3.2 Shortage of helium for MRI systems 58
3.3.4 WINNING IMPERATIVE 59
3.3.4.1 Increasing adoption of refurbished diagnostic imaging systems 59
3.3.4.2 Focusing on emerging markets 59
3.4 REGULATORY AFFAIRS 60
3.4.1 U.S. 60
3.4.2 EUROPE 61
3.4.3 CHINA 61
3.4.4 INDIA 62
3.4.5 JAPAN 62
3.5 PORTER'S FIVE FORCE ANALYSIS 63
3.5.1 THREAT OF NEW ENTRANTS 63
3.5.2 THREAT OF SUBSTITUTES 64
3.5.3 RIVALRY AMONG EXISTING COMPETITORS 65
3.5.4 BARGAINING POWER OF SUPPLIERS 65
3.5.5 BARGAINING POWER OF BUYERS 66
3.6 SUPPLY CHAIN ANALYSIS 66
3.7 PATENT TRENDS 68
3.8 EMERGING TECHNOLOGIES 76
3.8.1 ULTRASOUND 76
3.8.1.1 Automated breast ultrasound 76
3.8.1.2 Robotic ultrasound 76
3.8.1.3 Remote ultrasound 77
3.8.2 MRI 77
3.8.2.1 Ultra low field MRI 77
3.8.2.2 Magnetoencephalography (MEG) 77
3.8.2.3 Computer aided detection (CAD) for MRI 78
3.8.3 NUCLEAR IMAGING 78
3.8.3.1 Handheld gamma cameras 78
3.8.4 CT SCANS 78
3.8.4.1 Breast tomosynthesis 78
3.8.5 HYBRID SYSTEMS 79
3.8.5.1 PET/MRI 79
3.8.5.2 Photo acoustic tomography(PAT) 79
3.9 UPCOMING TECHNOLOGIES 80
3.10 MARKET SHARE ANALYSIS BY MAJOR PLAYERS 101
3.10.1 CT MARKET SHARE ANALYSIS BY MAJOR PLAYERS 104
3.10.2 MRI MARKET SHARE ANALYSIS BY MAJOR PLAYERS 105
3.10.3 ULTRASOUND MARKET SHARE ANALYSIS BY MAJOR PLAYERS 107
3.10.4 NUCLEAR IMAGING MARKET SHARE ANALYSIS BY MAJOR PLAYERS 109
3.10.5 X-RAY MARKET SHARE ANALYSIS BY MAJOR PLAYERS 111
3.10.6 MAMMOGRAPHY MARKET SHARE ANALYSIS BY MAJOR PLAYERS 112
4 DIAGNOSTIC IMAGING GLOBAL MARKET, BY PRODUCTS 114
4.1 INTRODUCTION 114
4.2 COMPUTED TOMOGRAPHY (CT) SCANNERS 117
4.2.1 STATIONARY COMPUTED TOMOGRAPHY 119
4.2.2 PORTABLE COMPUTED TOMOGRAPHY 120
4.3 NUCLEAR IMAGING (NI) EQUIPMENT 122
4.3.1 SINGLE PHOTON-EMISSION COMPUTED TOMOGRAPHY (SPECT) 125
4.3.2 POSITRON-EMISSION TOMOGRAPHY (PET) 126
4.4 MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS 128
4.4.1 OPEN SIDED MRI SYSTEM 131
4.4.2 CLOSED SYSTEM 133
4.4.3 OPEN STANDBY/ SITTING MRI 134
4.5 ULTRASOUND SCANNERS 136
4.5.1 TROLLEY/CART BASED ULTRASOUND SCANNERS 138
4.5.2 COMPACT/ PORTABLE ULTRASOUND SCANNER 139
4.6 X-RAY DEVICES 141
4.6.1 STATIONARY DEVICES 144
4.6.2 PORTABLE DEVICES 145
4.6.2.1 Mobile devices 147
4.6.2.2 Handheld devices 148
4.7 OTHERS 149
5 DIAGNOSTIC IMAGING GLOBAL MARKET, BY TECHNOLOGY 152
5.1 INTRODUCTION 152
5.2 CT 153
5.2.1 LOW SLICE CT 156
5.2.2 MEDIUM SLICE CT 157
5.2.3 HIGH SLICE CT 158
5.3 NUCLEAR IMAGING 160
5.3.1 SPECT 161
5.3.2 PET 162
5.4 MRI 164
5.4.1 LOW AND MIDDLE FIELD MRI 167
5.4.2 HIGH FIELD MRI 168
5.4.3 VERY HIGH FIELD MRI 169
5.5 ULTRASOUND 170
5.5.1 2D ULTRASOUND 172
5.5.2 3D AND 4D IMAGING 173
5.5.3 DOPPLER IMAGING 174
5.5.4 HIFU IMAGING 175
5.5.5 CONTRAST ULTRASOUND 177
5.5.6 ULTRASOUND ELASTOGRAPHY 178
5.5.7 OTHERS 179
5.6 X RAY 180
5.6.1 DIGITAL RADIOGRAPHY 183
5.6.2 COMPUTED RADIOGRAPHY 184
5.6.3 ANALOG RADIOGRAPHY 186
5.7 OTHERS 187
6 DIAGNOSTIC IMAGING GLOBAL MARKET, BY APPLICATION 189
6.1 INTRODUCTION 189
6.2 CARDIOVASCULAR DISEASES (CVD) 191
6.3 CANCER (ONCOLOGY) 194
6.4 NEUROLOGICAL DISORDERS 195
6.5 ABDOMINAL RELATED PROBLEMS 197
6.6 ORTHOPEDIC DISORDERS 199
6.7 GYNECOLOGY 201
6.8 OTHERS 203
7 DIAGNOSTIC IMAGING GLOBAL MARKET, BY END-USERS 205
7.1 INTRODUCTION 205
7.2 HOSPITALS 207
7.3 PRIVATE DIAGNOSTIC LABORATORIES 208
7.4 RESEARCH LABORATORIES 209
8 REGIONAL MARKET ANALYSIS 211
8.1 INTRODUCTION 211
8.2 NORTH AMERICA 213
8.2.1 U.S. 229
8.3 EUROPE 230
8.4 ASIA PACIFIC 246
8.5 REST OF WORLD (ROW) 261
9 COMPANY DEVELOPMENTS 276
9.1 INTRODUCTION 276
9.1.1 NEW PRODUCT LAUNCH AS A MAJOR GROWTH STRATEGY OF
DIAGNOSTIC IMAGING MARKET PLAYERS 276
9.2 NEW PRODUCT LAUNCH 278
9.3 APPROVALS 289
9.4 EXHIBITIONS 296
9.5 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS and JOINT VENTURES 302
9.6 MERGERS AND ACQUISITIONS 306
9.7 OTHER DEVELOPMENTS 308
10 MAJOR COMPANIES 311
10.1 ANALOGIC CORPORATION 311
10.1.1 OVERVIEW 311
10.1.2 FINANCIALS 312
10.1.3 PRODUCT PORTFOLIO 314
10.1.4 KEY DEVELOPMENTS 316
10.1.5 BUSINESS STRATEGY 318
10.1.6 SWOT ANALYSIS 319
10.2 CARESTREAM HEALTH, INC. 320
10.2.1 OVERVIEW 320
10.2.2 FINANCIALS 320
10.2.3 PRODUCT PORFOLIO 320
10.2.4 KEY DEVELOPMENTS 322
10.2.5 BUSINESS STRATEGY 324
10.2.6 SWOT ANALYSIS 325
10.3 GE HEALTHCARE 326
10.3.1 OVERVIEW 326
10.3.2 FINANCIALS 327
10.3.3 PRODUCT PORTFOLIO 329
10.3.4 KEY DEVELOPMENTS 334
10.3.5 BUSINESS STRATEGY 337
10.3.6 SWOT ANALYSIS 338
10.4 HITACHI MEDICAL CORPORATION 339
10.4.1 OVERVIEW 339
10.4.2 FINANCIALS 340
10.4.3 PRODUCT PORTFOLIO 342
10.4.4 KEY DEVELOPMENTS 344
10.4.5 BUSINESS STRATEGY 346
10.4.6 SWOT ANALYSIS 347
10.5 HOLOGIC, INC. 348
10.5.1 OVERVIEW 348
10.5.2 FINANCIALS 349
10.5.3 PRODUCT PORTFOLIO 351
10.5.4 KEY DEVELOPMENTS 353
10.5.5 BUSINESS STRATEGY 355
10.5.6 SWOT ANALYSIS 356
10.6 PHILIPS HEALTHCARE 357
10.6.1 OVERVIEW 357
10.6.2 FINANCIALS 358
10.6.3 PRODUCT PORTFOLIO 360
10.6.4 KEY DEVELOPMENTS 365
10.6.5 BUSINESS STRATEGY 368
10.6.6 SWOT ANALYSIS 369
10.7 SAMSUNG MEDISON 370
10.7.1 OVERVIEW 370
10.7.2 FINANCIALS 371
10.7.3 PRODUCT PORTFOLIO 373
10.7.4 KEY DEVELOPMENTS 375
10.7.5 BUSINESS STRATEGY 377
10.7.6 SWOT ANALYSIS 378
10.8 SHIMADZU CORPORATION 379
10.8.1 OVERVIEW 379
10.8.2 FINANCIALS 380
10.8.3 PRODUCT PORTFOLIO 382
10.8.4 KEY DEVELOPMENTS 384
10.8.5 BUSINESS STRATEGY 386
10.8.6 SWOT ANALYSIS 387
10.9 SIEMENS HEALTHCARE 388
10.9.1 OVERVIEW 388
10.9.2 FINANCIALS 389
10.9.3 PRODUCT PORTFOLIO 391
10.9.4 KEY DEVELOPMENTS 396
10.9.5 BUSINESS STRATEGY 401
10.9.6 SWOT ANALYSIS 402
10.10 TOSHIBA MEDICAL SYSTEMS CORPORATION 403
10.10.1 OVERVIEW 403
10.10.2 FINANCIALS 404
10.10.3 PRODUCT PORTFOLIO 406
10.10.4 KEY DEVELOPMENTS 408
10.10.5 BUSINESS STRATEGY 411
10.10.6 SWOT ANALYSIS 412

LIST OF TABLES

TABLE 1 DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 28
TABLE 2 DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY PRODUCT,
(2014-2022) ($MN) 29
TABLE 3 DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN) 31
TABLE 4 DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY END-USERS,
(2014-2022) ($MN) 32
TABLE 5 DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY PRODUCT,
(2014-2022) ($MN) 116
TABLE 6 COMPUTED TOMOGRAPHY (CT) SCANNERS GLOBAL MARKET REVENUE,
BY REGION, (2014-2022) ($MN) 118
TABLE 7 COMPUTED TOMOGRAPHY (CT) SCANNERS GLOBAL MARKET REVENUE,
BY PRODUCT, (2014-2022) ($MN) 119
TABLE 8 STATIONARY COMPUTED TOMOGRAPHY (CT) SCANNERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 120
TABLE 9 PORTABLE COMPUTED TOMOGRAPHY (CT) SCANNERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 122
TABLE 10 NUCLEAR IMAGING (NI) EQUIPMENT GLOBAL MARKET REVENUE,
BY REGION, (2014-2022) ($MN) 124
TABLE 11 NUCLEAR IMAGING (NI) EQUIPMENT GLOBAL MARKET REVENUE,
BY PRODUCT, (2014-2022) ($MN) 125
TABLE 12 SPECT IMAGING EQUIPMENT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 126
TABLE 13 PET IMAGING EQUIPMENT GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 127
TABLE 14 MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 130
TABLE 15 MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS GLOBAL MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN) 131
TABLE 16 MRI OPEN SYSTEM GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 132
TABLE 17 MRI CLOSED SYSTEM GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 134
TABLE 18 OPEN MRI STANDBY/ SITTING SYSTEM GLOBAL MARKET REVENUE,
BY REGION, (2014-2022) ($MN) 135
TABLE 19 ULTRASOUND SCANNERS GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 137
TABLE 20 ULTRASOUND SCANNERS GLOBAL MARKET REVENUE, BY PRODUCT,
(2014-2022) ($MN) 138
TABLE 21 TROLLEY/ CART BASED ULTRASOUND SCANNERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 139
TABLE 22 COMPACT/ PORTABLE ULTRASOUND SCANNERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 141
TABLE 23 X-RAY DEVICES GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 143
TABLE 24 X-RAY DEVICES GLOBAL MARKET REVENUE, BY PRODUCT,
(2014-2022) ($MN) 143
TABLE 25 STATIONARY X-RAY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 145
TABLE 26 PORTABLE X-RAY DEVICES GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 146
TABLE 27 PORTABLE X-RAY DEVICES GLOBAL MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN) 147
TABLE 28 PORTABLE MOBILE X-RAY DEVICES GLOBAL MARKET REVENUE,
BY REGION, (2014-2022) ($MN) 148
TABLE 29 PORTABLE HANDHELD X-RAY DEVICES GLOBAL MARKET REVENUE,
BY REGION, (2014-2022) ($MN) 149
TABLE 30 OTHER DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 150
TABLE 31 DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN) 153
TABLE 32 COMPUTED TOMOGRAPHY (CT) GLOBAL MARKET REVENUE,
BY TECHNOLOGY, (2014-2022) ($MN) 155
TABLE 33 LOW SLICE CT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 157
TABLE 34 MEDIUM SLICE CT GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 158
TABLE 35 HIGH SLICE CT GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 159
TABLE 36 NUCLEAR IMAGING (NI) GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN) 160
TABLE 37 SPECT IMAGING GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 162
TABLE 38 PET IMAGING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 164
TABLE 39 MAGNETIC RESONANCE IMAGING (MRI) GLOBAL MARKET REVENUE,
BY TECHNOLOGY, (2014-2022) ($MN) 167
TABLE 40 LOW AND MIDDLE FIELD MRI GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 168
TABLE 41 HIGH FIELD MRI GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 169
TABLE 42 VERY HIGH FIELD MRI GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 170
TABLE 43 ULTRASOUND SCANNERS GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN) 172
TABLE 44 2D ULTRASOUND GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 173
TABLE 45 3D AND 4D ULTRASOUND GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 174
TABLE 46 DOPPLER ULTRASONOGRAPHY GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 175
TABLE 47 HIFU IMAGING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 176
TABLE 48 CONTRAST ULTRASOUND GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 178
TABLE 49 ULTRASOUND ELASTOGRAPHY GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 179
TABLE 50 OTHER ULTRASOUND GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 180
TABLE 51 X-RAY IMAGING GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 182
TABLE 52 X-RAY IMAGING GLOBAL MARKET REVENUE, BY TECHNOLOGY,
(2014-2022) ($MN) 183
TABLE 53 DIGITAL RADIOGRAPHY X-RAY GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 184
TABLE 54 COMPUTED RADIOGRAPHY X-RAY GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 185
TABLE 55 ANALOG IMAGING X-RAY GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 186
TABLE 56 OTHER DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 187
TABLE 57 DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN) 191
TABLE 58 CARDIOVASCULAR DIAGNOSTIC IMAGING APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 193
TABLE 59 CANCER DIAGNOSTIC IMAGING APPLICATION GLOBAL MARKET REVENUE, BY REGION (2014-2022) ($MN) 195
TABLE 60 NEUROLOGICAL DISORDERS DIAGNOSTIC IMAGING APPLICATION GLOBAL MARKET REVENUE, BY REGION (2014-2022) ($MN) 197
TABLE 61 ABDOMINAL RELATED PROBLEMS DIAGNOSTIC IMAGING APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 199
TABLE 62 ORTHOPEDIC DIAGNOSTIC IMAGING APPLICATION GLOBAL MARKET REVENUE, BY REGION (2014-2022) ($MN) 201
TABLE 63 GYNECOLOGY DIAGNOSTIC IMAGING APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 203
TABLE 64 OTHER DIAGNOSTIC IMAGING APPLICATIONS GLOBAL MARKET REVENUE, BY REGION (2014-2022) ($MN) 204
TABLE 65 DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY END USERS,
(2014-2022) ($MN) 207
TABLE 66 HOSPITALS DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 208
TABLE 67 PRIVATE DIAGNOSTIC LABORATORIES GLOBAL MARKET REVENUE,
BY REGION (2014-2022) ($MN) 209
TABLE 68 RESEARCH LABORATORIES GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 210
TABLE 69 DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 213
TABLE 70 NORTH AMERICAN DIAGNOSTIC IMAGING MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN) 215
TABLE 71 NORTH AMERICAN COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET,
BY PRODUCT, (2014-2022) ($MN) 216
TABLE 72 NORTH AMERICAN NUCLEAR IMAGING (NI) EQUIPMENT MARKET REVENUE, BY PRODUCT (2014-2022) ($MN) 217
TABLE 73 NORTH AMERICAN MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN) 218
TABLE 74 NORTH AMERICAN ULTRASOUND SCANNERS MARKET REVENUE,
BY PRODUCT,(2014-2022) ($MN) 219
TABLE 75 NORTH AMERICAN X-RAY DEVICES MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN) 220
TABLE 76 NORTH AMERICAN PORTABLE X-RAY DEVICES MARKET REVENUE,
BY PRODUCT, (2014-2022) ($MN) 221
TABLE 77 NORTH AMERICAN DIAGNOSTIC IMAGING MARKET REVENUE,
BY TECHNOLOGY, (2014-2022) ($MN) 222
TABLE 78 NORTH AMERICAN COMPUTED TOMOGRAPHY (CT) MARKET REVENUE,
BY TECHNOLOGY, (2014-2022) ($MN) 223
TABLE 79 NORTH AMERICAN NUCLEAR IMAGING (NI) MARKET REVENUE,
BY TECHNOLOGY, (2014-2022) ($MN) 224
TABLE 80 NORTH AMERICAN MAGNETIC RESONANCE IMAGING (MRI) MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN) 225
TABLE 81 NORTH AMERICAN ULTRASOUND MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN) 226
TABLE 82 NORTH AMERICAN X-RAY IMAGING MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN) 227
TABLE 83 NORTH AMERICAN DIAGNOSTIC IMAGING MARKET REVENUE,
BY APPLICATION, (2014-2022) ($MN) 228
TABLE 84 NORTH AMERICAN DIAGNOSTIC IMAGING MARKET REVENUE,
BY END-USERS, (2014-2022) ($MN) 229
TABLE 85 EUROPEAN DIAGNOSTIC IMAGING MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN) 232
TABLE 86 EUROPEAN COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET,
BY PRODUCT, (2014-2022) ($MN) 233
TABLE 87 EUROPEAN NUCLEAR IMAGING (NI) EQUIPMENT MARKET REVENUE,
BY PRODUCT, (2014-2022) ($MN) 234
TABLE 88 EUROPEAN MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN) 235
TABLE 89 EUROPEAN ULTRASOUND SCANNERS MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN) 236
TABLE 90 EUROPEAN X-RAY DEVICES MARKET REVENUE, BY PRODUCT,
(2014-2022) ($MN) 237
TABLE 91 EUROPEAN PORTABLE X-RAY DEVICES MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN) 238
TABLE 92 EUROPEAN DIAGNOSTIC IMAGING MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN) 239
TABLE 93 EUROPEAN COMPUTED TOMOGRAPHY (CT) MARKET REVENUE,
BY TECHNOLOGY, (2014-2022) ($MN) 240
TABLE 94 EUROPEAN NUCLEAR IMAGING (NI) MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN) 241
TABLE 95 EUROPEAN MAGNETIC RESONANCE IMAGING (MRI) MARKET REVENUE,
BY TECHNOLOGY, (2014-2022) ($MN) 242
TABLE 96 EUROPEAN ULTRASOUND MARKET REVENUE, BY TECHNOLOGY,
(2014-2022) ($MN) 243
TABLE 97 EUROPEAN X-RAY IMAGING MARKET REVENUE, BY TECHNOLOGY,
(2014-2022) ($MN) 244
TABLE 98 EUROPEAN DIAGNOSTIC IMAGING MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN) 245
TABLE 99 EUROPEAN DIAGNOSTIC IMAGING MARKET REVENUE, BY END-USERS, (2014-2022) ($MN) 246
TABLE 100 ASIA PACIFIC DIAGNOSTIC IMAGING MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN) 250
TABLE 101 ASIA PACIFIC COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET,
BY PRODUCT, (2014-2022) ($MN) 251
TABLE 102 ASIA PACIFIC NUCLEAR IMAGING (NI) MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN) 251
TABLE 103 ASIA PACIFIC MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN) 252
TABLE 104 ASIA PACIFIC ULTRASOUND SCANNERS MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN) 253
TABLE 105 ASIA PACIFIC X-RAY DEVICES MARKET REVENUE, BY PRODUCT,
(2014-2022) ($MN) 254
TABLE 106 ASIA PACIFIC PORTABLE X-RAY DEVICES MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN) 254
TABLE 107 ASIA PACIFIC DIAGNOSTIC IMAGING MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN) 255
TABLE 108 ASIA PACIFIC COMPUTED TOMOGRAPHY (CT) MARKET REVENUE,
BY TECHNOLOGY, (2014-2022) ($MN) 256
TABLE 109 ASIA PACIFIC NUCLEAR IMAGING (NI) MARKET REVENUE,
BY TECHNOLOGY, (2014-2022) ($MN) 257
TABLE 110 ASIA PACIFIC MAGNETIC RESONANCE IMAGING (MRI) MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN) 257
TABLE 111 ASIA PACIFIC ULTRASOUND MARKET REVENUE, BY TECHNOLOGY,
(2014-2022) ($MN) 258
TABLE 112 ASIA PACIFIC X-RAY IMAGING MARKET REVENUE, BY TECHNOLOGY,
(2014-2022) ($MN) 259
TABLE 113 ASIA PACIFIC DIAGNOSTIC IMAGING MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN) 260
TABLE 114 ASIA PACIFIC DIAGNOSTIC IMAGING MARKET REVENUE, BY END-USERS, (2014-2022) ($MN) 261
TABLE 115 ROW DIAGNOSTIC IMAGING MARKET REVENUE, BY PRODUCT,
(2014-2022) ($MN) 264
TABLE 116 ROW COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET, BY PRODUCT, (2014-2022) ($MN) 265
TABLE 117 ROW NUCLEAR IMAGING (NI) MARKET REVENUE, BY PRODUCT,
(2014-2022) ($MN) 265
TABLE 118 ROW MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN) 266
TABLE 119 ROW ULTRASOUND SCANNERS MARKET REVENUE, BY PRODUCT,
(2014-2022) ($MN) 267
TABLE 120 ROW X-RAY DEVICES MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN) 267
TABLE 121 ROW PORTABLE X-RAY DEVICES MARKET REVENUE, BY PRODUCT,
(2014-2022) ($MN) 268
TABLE 122 ROW DIAGNOSTIC IMAGING MARKET REVENUE, BY TECHNOLOGY,
(2014-2022) ($MN) 269
TABLE 123 ROW COMPUTED TOMOGRAPHY (CT) MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN) 270
TABLE 124 ROW NUCLEAR IMAGING (NI) MARKET REVENUE, BY TECHNOLOGY,
(2014-2022) ($MN) 270
TABLE 125 ROW MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN) 271
TABLE 126 ROW ULTRASOUND MARKET REVENUE, BY TECHNOLOGY,
(2014-2022) ($MN) 272
TABLE 127 ROW X-RAY IMAGING MARKET REVENUE, BY TECHNOLOGY,
(2014-2022) ($MN) 273
TABLE 128 ROW DIAGNOSTIC IMAGING MARKET REVENUE, BY APPLICATION,
(2014-2022) ($MN) 274
TABLE 129 ROW DIAGNOSTIC IMAGING MARKET REVENUE, BY END-USERS,
(2014-2022) ($MN) 275
TABLE 130 NEW PRODUCT LAUNCHES (2013-2016) 278
TABLE 131 APPROVALS (2013-2016) 290
TABLE 132 EXHIBITIONS (2013-2015) 297
TABLE 133 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, and JOINT VENTURES (2013-2015) 302
TABLE 134 MERGERS AND ACQUISITIONS (2013-2015) 307
TABLE 135 OTHER DEVELOPMENTS (2013-2015) 309
TABLE 136 ANALOGIC CORPORATION: TOTAL REVENUE AND RandD EXPENSES,
(2013-2015) ($MN) 312
TABLE 137 ANALOGIC CORPORATION: TOTAL REVENUE, BY SEGMENTS,
(2013-2015) ($MN) 313
TABLE 138 ANALOGIC CORPORATION: TOTAL REVENUE, BY GEOGRAPHY,
(2013-2015) ($MN) 314
TABLE 139 GENERAL ELECTRIC COMPANY: TOTAL REVENUE AND RandD EXPENSES, (2013-2015) ($MN) 327
TABLE 140 GENERAL ELECTRIC COMPANY: TOTAL REVENUE, BY SEGMENT,
(2013-2015) ($MN) 328
TABLE 141 GENERAL ELECTRIC COMPANY: TOTAL REVENUE, BY GEOGRAPHY,
(2013-2015) ($MN) 329
TABLE 142 HITACHI MEDICAL CORPORATION: TOTAL REVENUE AND RandD EXPENSES, (2013-2015) ($MN) 340
TABLE 143 HITACHI MEDICAL CORPORATION: TOTAL REVENUE, BY SEGMENT,
(2013-2015) ($MN) 341
TABLE 144 HITACHI MEDICAL CORPORATION: TOTAL REVENUE, BY REGION,
(2013-2015) ($MN) 342
TABLE 145 HOLOGIC, INC.: TOTAL REVENUE AND RandD EXPENSES (2013-2015) ($MN) 349
TABLE 146 HOLOGIC, INC.: PRODUCT SALES REVENUE, BY SEGMENT,
(2013-2015) ($MN) 350
TABLE 147 HOLOGIC, INC. : TOTAL REVENUE, BY REGION, (2013-2015) ($MN) 351
TABLE 148 PHILIPS N.V.: TOTAL REVENUE AND RandD EXPENSES, (2013-2015) ($MN) 358
TABLE 149 PHILIPS N.V.: TOTAL REVENUE, BY SEGMENT, (2013-2015) ($MN) 359
TABLE 150 PHILIPS HEALTHCARE: TOTAL REVENUE, BY GEOGRAPHY,
(2013-2015) ($MN) 360
TABLE 151 SAMSUNG: TOTAL REVENUE AND RandD EXPENSES, (2013-2015) ($MN) 371
TABLE 152 SAMSUNG: TOTAL REVENUE, BY SEGMENT, (2013-2015) ($MN) 372
TABLE 153 SAMSUNG: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN) 373
TABLE 154 SHIMADZU CORPORATION: TOTAL REVENUE AND OPERATING EXPENSES, (2013-2015) ($MN) 380
TABLE 155 SHIMADZU CORPORATION: TOTAL REVENUE, BY SEGMENT,
(2013-2015) ($MN) 381
TABLE 156 SHIMADZU CORPORATION: TOTAL REVENUE, BY GEOGRAPHY,
(2013-2015) ($MN) 382
TABLE 157 SIEMENS AG: TOTAL REVENUE AND RandD EXPENSES, (2013-2015) ($MN) 389
TABLE 158 SIEMENS AG: TOTAL REVENUE, BY SEGMENT, (2013-2015) ($MN) 390
TABLE 159 SIEMENS AG: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN) 391
TABLE 160 TOSHIBA CORPORATION: TOTAL REVENUE AND RandD EXPENSES,
(2013-2015) ($MN) 404
TABLE 161 TOSHIBA CORPORATION: TOTAL REVENUE, BY SEGMENT,
(2013-2015) ($MN) 405
TABLE 162 TOSHIBA CORPORATION: TOTAL REVENUE, BY GEOGRAPHY,
(2013-2015) ($MN) 406


































LIST OF FIGURES


FIGURE 1 GLOBAL DIAGNOSTIC IMAGING MARKET SHARE AND REVENUE, BY REGION (2014-2022) ($MN) 27
FIGURE 2 DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2015) ($MN) 30
FIGURE 3 DIAGNOSTIC IMAGING GLOBAL MARKET: RESEARCH APPROACH 39
FIGURE 4 DIAGNOSTIC IMAGING GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH 40
FIGURE 5 DIAGNOSTIC IMAGING GLOBAL MARKET: FORECASTING MODEL 41
FIGURE 6 DIAGNOSTIC IMAGING GLOBAL MARKET: MARKET BREAKDOWN and DATA TRIANGULATION 42
FIGURE 7 DIAGNOSTIC IMAGING MARKET: MARKET SEGMENTATION 48
FIGURE 8 MARKET DYNAMICS 49
FIGURE 9 DIAGNOSTIC IMAGING GLOBAL MARKET: PORTER'S ANALYSIS 64
FIGURE 10 DIAGNOSTIC IMAGING GLOBAL MARKET: SUPPLY CHAIN ANALYSIS 67
FIGURE 11 DIAGNOSTIC IMAGING (CT,MRI,ULTRASOUND,X-RAY,NUCLEAR IMAGING, MAMMOGRAPHY): PCT APPLICATION FILING BY MODALITIES, (2011-2015) 69
FIGURE 12 COMPUTED TOMOGRAPHY (DIAGNOSTIC IMAGING): PCT APPLICATION FILING BY MAJOR PLAYERS, (2011-2015) 70
FIGURE 13 MAGNETIC RESONANCE IMAGING (DIAGNOSTIC IMAGING): PCT APPLICATION FILING BY MAJOR PLAYERS, (2011-2015) 71
FIGURE 14 ULTRASOUND IMAGING (DIAGNOSTIC IMAGING): PCT APPLICATION FILING BY MAJOR PLAYERS, (2011-2015) 72
FIGURE 15 X-RAY (DIAGNOSTIC IMAGING): PCT APPLICATION FILING BY MAJOR PLAYERS, (2011-2015) 73
FIGURE 16 NUCLEAR IMAGING (DIAGNOSTIC IMAGING): PCT APPLICATION FILING BY MAJOR PLAYERS, (2011-2015) 74
FIGURE 17 MAMMOGRAPHY (DIAGNOSTIC IMAGING): PCT APPLICATION FILING BY MAJOR PLAYERS, (2011-2015) 75
FIGURE 18 DIAGNOSTIC IMAGING GLOBAL MARKET SHARE ANALYSIS,
BY KEY PLAYERS, 2015 (%) 101
FIGURE 19 CT GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2015 (%) 104
FIGURE 20 MRI GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2015 (%) 105
FIGURE 21 ULTRASOUND GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS,
2015 (%) 107
FIGURE 22 GLOBAL NUCLEAR IMAGING MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2015 (%) 109
FIGURE 23 GLOBAL X-RAY IMAGING MARKET SHARE ANALYSIS, BY KEY PLAYERS,
2015 (%) 111
FIGURE 24 MAMMOGRAPHY GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS,
2015 (%) 112
FIGURE 25 DIAGNOSTIC IMAGING GLOBAL MARKET SCENARIO, BY PRODUCT OUTLOOK (2015) 115
FIGURE 26 NUCLEAR IMAGING (NI) EQUIPMENT GLOBAL MARKET SHARE, BY PRODUCT TYPE, (2015 V'S 2022) (%) 123
FIGURE 27 MRI GLOBAL MARKET SHARE, BY PRODUCT TYPE, (2015 V'S 2022) (%) 130
FIGURE 28 COMPUTED TOMOGRAPHY (CT) GLOBAL MARKET SHARE, BY TECHNOLOGY TYPE, (2015 V'S 2022) (%) 155
FIGURE 29 MAGNETIC RESONANCE IMAGING (MRI) GLOBAL MARKET SHARE,
BY TECHNOLOGY, (2015 V'S 2022) (%) 166
FIGURE 30 ULTRASOUND SCANNERS GLOBAL MARKET SHARE, BY TECHNOLOGY,
2015 (%) 171
FIGURE 31 X-RAY IMAGING GLOBAL MARKET SHARE, BY TECHNOLOGY,
(2014-2022) (%) 181
FIGURE 32 DIAGNOSTIC IMAGING GLOBAL MARKET SHARE, BY APPLICATION,
2015 (%), CAGR (%) 190
FIGURE 33 DIAGNOSTIC IMAGING GLOABL MARKET REVENUE, BY END USERS,
(2015 V'S 2022) ($MN) 206
FIGURE 34 DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN), CAGR (%) 212
FIGURE 35 NORTH AMERICAN DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE,
BY TECHNOLOGY, APPLICATION and END USERS, (2015 V'S 2022) ($MN) 214
FIGURE 36 EUROPEAN DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE,
BY APPLICATION, TECHNOLOGY and END USERS (2015 V'S 2022) ($MN) 231
FIGURE 37 ASIA PACIFIC DIAGNOSTIC IMAGING MARKET REVENUE, BY TECHNOLOGY, APPLICATION and END-USERS, (2015 V'S 2022), ($MN) 249
FIGURE 38 ROW DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY APPLICATION, TECHNOLOGY and END-USERS, (2015 V'S 2022), ($MN) 263
FIGURE 39 KEY GROWTH STRATEGIES, (2013-2016) 277
FIGURE 40 SWOT: ANALOGIC CORPORATION 319
FIGURE 41 SWOT: CARESTREAM HEALTH, INC. 325
FIGURE 42 SWOT: GE HEALTHCARE 338
FIGURE 43 SWOT: HITACHI MEDICAL CORPORATION, INC. 347
FIGURE 44 SWOT: HOLOGIC, INC. 356
FIGURE 45 SWOT: PHILIPS HEALTHCARE 369
FIGURE 46 SWOT: SAMSUNG MEDISON 378
FIGURE 47 SWOT: SHIMADZU CORPORATION 387
FIGURE 48 SWOT: SIEMENS HEALTHCARE 402
FIGURE 49 SWOT: TOSHIBA MEDICAL SYSTEMS CORPORATION 412

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Global Diagnostic Imaging Market: Future Horizons and Growth Strategies--Business Assessments of Leading Suppliers

Global Diagnostic Imaging Market: Future Horizons and Growth Strategies--Business Assessments of Leading Suppliers

  • $ 14500
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $14,500.  Individual company assessments $2,450.  The report is available by company, section, market segment, and can be custom-tailored to your specific information needs and budget. ...

X-Ray Equipment Market: Future Horizons and Growth Strategies--Business Assessments of Leading Suppliers--M&A, Technological Capabilities, Marketing Tactics, Joint Ventures, Strategic Directions

X-Ray Equipment Market: Future Horizons and Growth Strategies--Business Assessments of Leading Suppliers--M&A, Technological Capabilities, Marketing Tactics, Joint Ventures, Strategic Directions

  • $ 7400
  • Industry report
  • September 2016
  • by Venture Planning Group

This report provides diagnostic imaging industry executives with strategically significant competitor information, analysis and insight crucial to the development and implementation of effective business, ...

Computed Tomography (CT) Market: Future Horizons and Growth Strategies--Business Assessments of Leading Suppliers--M&A, Technological Capabilities, Marketing Tactics, Joint Ventures, Strategic Directions

Computed Tomography (CT) Market: Future Horizons and Growth Strategies--Business Assessments of Leading Suppliers--M&A, Technological Capabilities, Marketing Tactics, Joint Ventures, Strategic Directions

  • $ 7400
  • Industry report
  • September 2016
  • by Venture Planning Group

This report provides diagnostic imaging industry executives with strategically significant competitor information, analysis and insight crucial to the development and implementation of effective business, ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.